Eteplirsen for the treatment of Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Eteplirsen for the treatment of Duchenne muscular dystrophy

Published:2013-09-10 Issue:5 Volume:74 Page:637-647
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Mendell Jerry R.¹²³⁴,Rodino‐Klapac Louise R.¹⁴,Sahenk Zarife¹²³⁴,Roush Kandice⁵,Bird Loren⁵,Lowes Linda P.⁴,Alfano Lindsay⁴,Gomez Ann Maria¹⁴,Lewis Sarah¹⁴,Kota Janaiah¹⁴,Malik Vinod¹⁴,Shontz Kim¹⁴,Walker Christopher M.¹⁴⁶,Flanigan Kevin M.¹²³⁴,Corridore Marco⁷,Kean John R.⁴⁷,Allen Hugh D.¹⁴,Shilling Chris¹³⁴,Melia Kathleen R.⁸,Sazani Peter⁸,Saoud Jay B.⁸,Kaye Edward M.⁸,

Affiliation:

1. Departments of PediatricsOhio State UniversityColumbus OH

2. Neurology the Ohio State UniversityOhio State UniversityColumbus OH

3. Gene Therapy CenterNationwide Children's Hospital Ohio State UniversityColumbus OH

4. Paul D. Wellstone CenterNationwide Children's Hospital Ohio State UniversityColumbus OH

5. Department of Pediatrics Clinical Research ServicesNationwide Children's Hospital Ohio State UniversityColumbus OH

6. Center for Vaccines and ImmunityNationwide Children's Hospital Ohio State UniversityColumbus OH

7. Departments of Surgery and AnesthesiologyNationwide Children's HospitalColumbus OH

8. Sarepta TherapeuticsCambridge MA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.23982

Reference33 articles.

1. Evidence-based path to newborn screening for duchenne muscular dystrophy

2. Duchenne Muscular Dystrophy

3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

4. Quality of Life, Physical Disability, and Respiratory Impairment in Duchenne Muscular Dystrophy

5. Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients;Passamano L;Acta Myol,2012

Cited by 587 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy;Pediatric Neurology;2024-04

2. Breaking the mold with RNA—a “RNAissance” of life science;npj Genomic Medicine;2024-01-09

3. RNA therapeutics history and future perspectives;Progress in Molecular Biology and Translational Science;2024

4. Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges;Cell Chemical Biology;2024-01

5. Gene Therapy for Genetic Muscle Diseases;Korean Journal of Neuromuscular Disorders;2023-12-31